Visual and Quantitative 82-Rb Uptake in Malignant Tumors on PET/CT
CONCLUSIONS: Malignant lesions can be readily depicted and their uptake quantified on Rb PET/CT. As such, Rb PET/CT has the potential to replace thallium in brain SPECT and other areas. Furthermore, Rb PET/CT should be explored in diagnosing and therapy monitoring of highly perfused tumors such as clear cell renal cell cancer. This new area of potential PET utilization warrants further investigation. Our preliminary data represent a first step in that direction.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Commander, C., Desai, H., Oldan, J., Wong, T., Ivanovic, M., Khandani, A. Tags: Other Solid Tumors Posters Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Carcinoid Tumor | Kidney Cancer | Liver | Lung Cancer | Lymphoma | Neurology | Non-Small Cell Lung Cancer | Nuclear Medicine | Radiology | Renal Cell Carcinoma | SPECT | Urology & Nephrology